There's been a change in patent exclusivity for certain times of drugs because of this inflation reduction act. It can be very frustrating, especially when you see in your own lab side by side the investment you can get for an oncology product versus a tuberculosis product. If you want to make a medicine for a rare disease where there aren't that many patients and it's not as profitable, there's a difficult tightrope you have to walk here.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode